Successful Clinical Trials

The performance of the RBS TB Breathalyser has been validated in a series of clinical trials with over 500 patients within a hospital environment. In addition, the system has successfully passed completely independent trials in Ethiopia under the supervision of the London School of Hygiene and Tropical Medicine and at the WHO-approved Shri K. J. Mehta TB hospital in India.

A trial is also currently in progress at a further WHO-approved hospital in South Africa, results of which are expected in December 2008.